Abbygail Foster is a Principal Scientist and Cell Therapy Team Lead, Pharmaceutical Development at Genentech. As team lead, she oversees several cell therapy programs in various stages of clinical development. Prior to her current role, Abby was the formulation lead for one of Genentech’s T-cell bispecific antibody programs and was responsible for supporting Phase 1 through Phase 3 development efforts.

Abby received her Ph.D. in Chemical Engineering from the University of Delaware. She then held positions as an NIH Postdoctoral fellow and as an Instructor/NIH Research Career Development (K) Awardee in the Department of Materials Science and Engineering and the Cardiovascular Institute at Stanford University.

Talks

• In-use physicochemical stability studies: Strategies to support the clinical administration of cell therapies